ALYMSYS
- Product NDC
- 85006-1754
- 11-digit product format
- 850061754
- Labeler code
- 85006
- Product ID
- 85006-1754_25c471d4-a4c1-4f99-8848-c49ce5b0000a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bevacizumab-maly
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Valorum Biologics, LLC
- Application
- BLA761231
- Marketing category
- BLA
- Marketing start
- 2026-03-30
- Substance
- BEVACIZUMAB-MALY
- Active strength
- 100 mg/4mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ALYMSYS
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BEVACIZUMAB-MALY | 100 mg/4mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 2S9ZZM9Q9V |
| Rxcui | 2599043, 2599049, 2599051, 2599052 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85006-1754-1 | ALYMSYS | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 7 | |
| 85006-1754-1 | ALYMSYS | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85006-1754-1 | ML - Milliliter | 85006-1754 | 8bd3c3a5-342c-4156-8d82-ea39dbc00327 | 1 | 2026-04-20 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2599049 | Alymsys 100 MG in 4 ML Injection | PSN | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599052 | Alymsys 400 MG in 16 ML Injection | PSN | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599043 | bevacizumab-maly 100 MG in 4 ML Injection | PSN | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599051 | bevacizumab-maly 400 MG in 16 ML Injection | PSN | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599052 | 16 ML bevacizumab-maly 25 MG/ML Injection [Alymsys] | SBD | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599049 | 4 ML bevacizumab-maly 25 MG/ML Injection [Alymsys] | SBD | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599051 | 16 ML bevacizumab-maly 25 MG/ML Injection | SCD | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599043 | 4 ML bevacizumab-maly 25 MG/ML Injection | SCD | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599049 | Alymsys 100 MG per 4 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599052 | Alymsys 25 MG/ML per 16 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599049 | Alymsys 25 MG/ML per 4 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599052 | Alymsys 400 MG per 16 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599043 | bevacizumab-maly 100 MG per 4 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599051 | bevacizumab-maly 25 MG/ML per 16 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599043 | bevacizumab-maly 25 MG/ML per 4 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
| 2599051 | bevacizumab-maly 400 MG per 16 ML Injection | SY | 42b4f96e-1f70-2126-e063-6294a90a93e3 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 85006-1754-1 | 85006175401 | 1 VIAL in 1 CARTON (85006-1754-1) / 4 mL in 1 VIAL | 1 vial | 2026-03-30 | No | No | Historical |